Products designed to treat low testosterone levels in men, also referred to as “low-T,” have been linked to serious side-effects that can be extremely dangerous. While the Federal Food and Drug Administration (FDA) has not issued a recall, it did issue a safety communication in January of 2014 advising the public that the agency was investigating whether testosterone replacement therapy drugs increased patients’ risk of adverse cardiac events, including heart attack and stroke.
Has There Been a Testosterone Replacement Therapy Recall?
Posted August 4, 2014 in Product News and Recalls | Testosterone Therapy
Auxilium and Prasco Partner to Introduce Generic Testim
Posted July 11, 2014 in Product News and Recalls | Testosterone Therapy
Auxilium Pharmaceuticals, Inc. and Prasco, LLC have partnered to introduce an authorized generic version of Testim, a drug for testosterone therapy. Testim is a drug prescribed to treat adult men who suffer from no or low testosterone, also known as Low-T.
Prasco already has inventory of its generic product and has begun shipping the drugs. Auxilium will maintain responsibility for the manufacturing of Testim and its distribution, and will now also accept liability for the generic version of ...
continue reading...
